Identification of the adult human hemangioblast.

Recent studies show that human CD133(+) (previously known as AC133(+)) cells from mobilized peripheral blood consist of stem cells with either hematopoietic or endothelial potential. To test whether this population also contains individual precursors with both capacities, the defining characteristics of the elusive adult hemangioblast, we developed a culture system that allows single-cell analyses of differentiation. In the presence of vascular endothelial growth factor (VEGF), stem cell growth factor (SCGF), and FLT-3 ligand, CD133(+)-enriched cells were first expanded and the amplified cells were transduced with a vector encoding an enhanced green fluorescent protein (EGFP) marker gene. Single EGFP(+) cells were then cocultured with corresponding non-transduced cells from the same experiment, yielding 50-100 marked cells in 8% of the wells after 2 weeks. The resultant cells were divided and differentiated with either granulocyte colony-stimulating factor (G-CSF) or with SCGF and VEGF. These culture conditions resulted in the formation of neutrophil or endothelial cells, respectively, as identified morphologically and by phenotypic staining. Dual differentiation of EGFP(+) cells could be observed in one-quarter of clones from single-seeded cells, suggesting that 2% of EGFP(+) cells were in fact human hemangioblasts. These cells could be expanded for at least 28 days without losing this dual capacity. Hence, this culture system may be of clinical relevance in the development of cellular therapies for disorders involving hematopoiesis and the vascular system. In addition, our results provide important information related to the development of the vasculature and the potential role of hemangioblasts in vasculogenesis in adult humans.

[1]  P. Kingsley,et al.  Lineage analysis of the hemangioblast as defined by FLK1 and SCL expression , 2002, Development.

[2]  C. Peschle,et al.  Identification of the hemangioblast in postnatal life. , 2002 .

[3]  E. Scott,et al.  Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization , 2002, Nature Medicine.

[4]  Kyunghee Choi The hemangioblast: a common progenitor of hematopoietic and endothelial cells. , 2002, Journal of hematotherapy & stem cell research.

[5]  A. Zander,et al.  Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vessels. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  M. Letarte,et al.  Expression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursors. , 2001, Blood.

[7]  V. Muzykantov,et al.  Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[8]  C. Baum,et al.  Influence of multiplicity of infection and protein stability on retroviral vector-mediated gene expression in hematopoietic cells , 2001, Gene Therapy.

[9]  W. Daniel,et al.  Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. , 2001, Cardiovascular research.

[10]  G. Hodge,et al.  Synthesis and Surface Expression of CD14 by Human Endothelial Cells , 2001, Infection and Immunity.

[11]  S. Shapiro,et al.  Contribution of Monocytes/Macrophages to Compensatory Neovascularization: The Drilling of Metalloelastase-Positive Tunnels in Ischemic Myocardium , 2000, Circulation research.

[12]  F. C. Lucibello,et al.  Endothelial-like cells derived from human CD14 positive monocytes. , 2000, Differentiation; research in biological diversity.

[13]  T. Murohara,et al.  Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. , 2000, The Journal of clinical investigation.

[14]  K. Pantel,et al.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells , 2000 .

[15]  A. Zannettino,et al.  Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues. , 2000, Blood.

[16]  S. Dirnhofer,et al.  Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells , 2000, The Lancet.

[17]  M. Bhatia,et al.  Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7. , 2000, Blood.

[18]  Patrick W. Faloon,et al.  Basic fibroblast growth factor positively regulates hematopoietic development. , 2000, Development.

[19]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Rutella,et al.  CD34+/CD105+ cells are enriched in primitive circulating progenitors residing in the G0 phase of the cell cycle and contain all bone marrow and cord blood CD34+/CD38low/− precursors , 2000, British journal of haematology.

[21]  S. Rafii,et al.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.

[22]  M. Boyer,et al.  Isolation of endothelial cells and their progenitor cells from human peripheral blood. , 2000, Journal of vascular surgery.

[23]  R. Hebbel,et al.  Origins of circulating endothelial cells and endothelial outgrowth from blood. , 2000, The Journal of clinical investigation.

[24]  E. J. de la Rosa,et al.  Endoglin is expressed in the chicken vasculature and is involved in angiogenesis , 1999, FEBS letters.

[25]  A. Zander,et al.  Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements , 1999, Gene Therapy.

[26]  C. Peschle,et al.  KDR receptor: a key marker defining hematopoietic stem cells. , 1999, Science.

[27]  N. Koide,et al.  Production of tissue factor in CD14-expressing human umbilical vein endothelial cells by lipopolysaccharide. , 1999, FEMS microbiology letters.

[28]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[29]  Hiroshi Takahashi,et al.  Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon , 1999, Nature Medicine.

[30]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[31]  B. Lord,et al.  CD34+AC133+ Cells Isolated from Cord Blood are Highly Enriched in Long‐Term Culture‐Initiating Cells, NOD/SCID‐Repopulating Cells and Dendritic Cell Progenitors , 1998, Stem cells.

[32]  B. Göttgens,et al.  The SCL gene specifies haemangioblast development from early mesoderm , 1998, The EMBO journal.

[33]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[34]  S. Shaw,et al.  Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. , 1998, Circulation research.

[35]  S. Nishikawa,et al.  Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. , 1998, Development.

[36]  M. Kennedy,et al.  A common precursor for hematopoietic and endothelial cells. , 1998, Development.

[37]  K. Alitalo,et al.  Avian VEGF-C: cloning, embryonic expression pattern and stimulation of the differentiation of VEGFR2-expressing endothelial cell precursors. , 1998, Development.

[38]  J. Kearney,et al.  AC133, a novel marker for human hematopoietic stem and progenitor cells. , 1997, Blood.

[39]  J. Wagner,et al.  Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. , 1997, Blood.

[40]  R. Warnke,et al.  A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. , 1997, Blood.

[41]  Janet Rossant,et al.  A Requirement for Flk1 in Primitive and Definitive Hematopoiesis and Vasculogenesis , 1997, Cell.

[42]  A. Ullrich,et al.  Flk-1 expression defines a population of early embryonic hematopoietic precursors. , 1997, Development.

[43]  A. Eichmann,et al.  Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[45]  P. J. Newman,et al.  The biology of PECAM-1. , 1997, The Journal of clinical investigation.

[46]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[47]  P. Quesenberry,et al.  Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. , 1996, Blood.

[48]  J. Folkman Clinical Applications of Research on Angiogenesis , 1995 .

[49]  L. Zon,et al.  Cloche, an early acting zebrafish gene, is required by both the endothelial and hematopoietic lineages. , 1995, Development.

[50]  C. Begley,et al.  Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[52]  S. Wright,et al.  CD14 and innate recognition of bacteria. , 1995, Journal of immunology.

[53]  L. Lasky,et al.  The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. , 1995, Blood.

[54]  P. Lansdorp,et al.  CD45 isoform expression on human haemopoietic cells at different stages of development , 1994, British journal of haematology.

[55]  A. Anagnostou,et al.  Erythropoietin receptor mRNA expression in human endothelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Jordan,et al.  The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis , 1994 .

[57]  S. Heimfeld,et al.  Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin , 1993 .

[58]  P. Lansdorp,et al.  Expression of Thy-1 on human hematopoietic progenitor cells , 1993, The Journal of experimental medicine.

[59]  A. Ullrich,et al.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis , 1993, Cell.

[60]  L. To,et al.  Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. , 1992, Blood.

[61]  I. Weissman,et al.  Isolation of a candidate human hematopoietic stem-cell population. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[62]  P. Lansdorp,et al.  Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. , 1991, Blood.

[63]  T. Doetschman,et al.  Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. , 1988, Development.

[64]  P. Murray The development in vitro of the blood of the early chick embryo , 1932 .

[65]  F. Sabin Studies on the origin of blood vessels and of red corpuscles as seen in the living blastoderm of the chick during the second day of incubation , 1920 .